Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 399 of 1,261
  1. US 10774128

    IL-33 antagonists and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  2. US 10774141

    Antibody for binding to interleukin 4 receptor

    SuZhou Connect Biopharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  3. US 10774330

    Reduced size self-delivering RNAI compounds

    Phio Pharmaceuticals Corp. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  4. US 10774334

    Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  5. US 10774333

    Modulators of PNPLA3 expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  6. US 10774344

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  7. US 10774390

    Methods and compositions for modulating PrfA mediated virulence gene activation in Listeria spp

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  8. WO 2020178316

    AZAINDAZOLES EN 5 OU 7 UTILISÉS COMME INHIBITEURS DE BÊTA-LACTAMASE

    ACRAF [IT] · Granted Sep 10, 2020 · Expires Sep 5, 2040

    granted
  9. CA 3131817

    FORMES POSOLOGIQUES D'HORMONE DE CROISSANCE A ACTION PROLONGEE AYANT UNE EFFICACITE SUPERIEURE A UNE DOSE DE SOMATROPINE QUOTIDIENNE

    ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S [DK] · Granted Sep 10, 2020 · Expires Sep 5, 2040

    granted
  10. US 10765691

    Method for treating crohn's disease using triple antimicrobial all-in-one formulation

    RedHill Biopharma Ltd. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  11. US 10767179

    MicroRNA composition for the treatment of neuroblastoma

    The Board of Regents of the University of Texas System · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  12. US 10766892

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  13. US 10765760

    Exon skipping oligomer conjugates for muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  14. US 10765666

    Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering

    OVID THERAPEUTICS INC. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  15. US 10765627

    Immunogenic composition against Campylobacter jejuni

    United States of America as represented by the Secretary of the Air Force · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  16. US 10765705

    Visco-supplement compositions, and methods of use thereof

    Prime Merger Sub, LLC · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  17. US 10766877

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  18. US 10765694

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  19. US 10766903

    Piperidine derivatives as inhibitors of ubiquitin specific protease 7

    ALMAC DISCOVERY LIMITED · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  20. US 10766927

    Peptides that stimulate subcutaneous adipogenesis

    The Regents of the University of California · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  21. US 10766908

    Calcium L-lactate frameworks as naturally degradable carriers

    The Regents of the University of California · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  22. US 10766925

    Opioid receptor modulators

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  23. US 10766902

    Wee-1 inhibiting pyrazolopyrimidinone compounds

    ALMAC DISCOVERY LIMITED · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  24. US 10766869

    Triazoles for the treatment of demyelinating dieases

    Vertex Pharmaceuticals Incorporated · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.